|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 225.76 USD | -0.25% |
|
+3.12% | +9.86% |
| 02-06 | UBS Adjusts Cardinal Health Price Target to $260 From $250, Maintains Buy Rating | MT |
| 02-06 | Evercore ISI Adjusts Cardinal Health Price Target to $260 From $250 | MT |
| Capitalization | 53.12B 44.64B 40.8B 38.86B 72.11B 4,819B 74.96B 475B 188B 2,316B 199B 195B 8,290B | P/E ratio 2026 * |
27.4x | P/E ratio 2027 * | 24.3x |
|---|---|---|---|---|---|
| Enterprise value | 58.47B 49.13B 44.9B 42.77B 79.37B 5,304B 82.51B 523B 207B 2,549B 219B 215B 9,124B | EV / Sales 2026 * |
0.23x | EV / Sales 2027 * | 0.2x |
| Free-Float |
89.22% | Yield 2026 * |
0.92% | Yield 2027 * | 0.93% |
More valuation ratios
* Estimated data
More news
Last Transcript: Cardinal Health, Inc.
More recommendations
More press releases
More news
| 1 day | -0.25% | ||
| 1 week | +3.12% | ||
| Current month | +5.06% | ||
| 1 month | +12.26% | ||
| 3 months | +10.85% | ||
| 6 months | +43.42% | ||
| Current year | +9.86% |
| 1 week | 205.87 |  | 230.81 |
| 1 month | 199.94 | | 230.81 |
| Current year | 199.94 | | 230.81 |
| 1 year | 120.72 | | 230.81 |
| 3 years | 68.53 | | 230.81 |
| 5 years | 45.85 | | 230.81 |
| 10 years | 39.05 | | 230.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jason Hollar
CEO | Chief Executive Officer | 53 | 31/08/2022 |
Aaron Alt
DFI | Director of Finance/CFO | 55 | 09/02/2023 |
Michelle Greene
CTO | Chief Tech/Sci/R&D Officer | 56 | 31/07/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gregory Kenny
CHM | Chairman | 73 | 31/10/2018 |
| Director/Board Member | 73 | 11/09/2013 | |
Nancy Killefer
BRD | Director/Board Member | 71 | 13/09/2015 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.25% | +3.12% | +77.25% | +188.47% | 53.26B | |
| +1.44% | +13.68% | +61.55% | +165.57% | 116B | |
| -0.80% | -1.59% | +9.19% | - | 25.24B | |
| -0.25% | +1.17% | +4.07% | -25.49% | 9.18B | |
| +0.95% | +1.91% | +7.11% | +6.37% | 8.47B | |
| +0.17% | +1.05% | -14.87% | -7.49% | 8.33B | |
| +0.80% | +3.08% | +22.86% | +33.82% | 6.4B | |
| +2.78% | -9.62% | -8.72% | +28.03% | 5.78B | |
| -1.59% | +3.50% | - | - | 3.85B | |
| Average | +0.37% | +2.71% | +19.80% | +55.61% | 26.3B | |
| Weighted average by Cap. | +0.65% | +8.31% | +49.68% | +141.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 259B 217B 199B 189B 351B 23,454B 365B 2,311B 914B 11,271B 970B 950B 40,347B | 282B 237B 216B 206B 382B 25,545B 397B 2,517B 996B 12,276B 1,056B 1,034B 43,944B |
| Net income | 2.03B 1.71B 1.56B 1.49B 2.76B 184B 2.87B 18.15B 7.18B 88.54B 7.62B 7.46B 317B | 2.14B 1.8B 1.65B 1.57B 2.91B 194B 3.02B 19.15B 7.58B 93.39B 8.04B 7.87B 334B |
| Net Debt | 5.35B 4.49B 4.11B 3.91B 7.26B 485B 7.54B 47.78B 18.91B 233B 20.05B 19.64B 834B | 4.4B 3.7B 3.38B 3.22B 5.98B 400B 6.22B 39.36B 15.58B 192B 16.52B 16.18B 687B |
More financial data
* Estimated data
Employees
55,392
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/02/26 | 225.76 $ | -0.25% | 1,419,987 |
| 06/02/26 | 226.32 $ | -0.38% | 2,250,733 |
| 05/02/26 | 227.18 $ | +9.83% | 3,583,568 |
| 04/02/26 | 206.85 $ | -5.11% | 2,504,363 |
| 03/02/26 | 218.00 $ | -0.42% | 1,890,452 |
Delayed Quote Nyse, February 09, 2026 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
225.76USD
Average target price
244.33USD
Spread / Average Target
+8.23%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CAH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition